Request a Demo
From novel proteins and bioactive substances to fibre isolates, botanicals, functional ingredients and precision-fermentation inputs, businesses are increasingly asking the same question: can this be legally sold as food in Australia?
This webinar examines the regulation of novel foods in Australia and New Zealand, including the public-health function of Australia New Zealand Food Standards Code (ANZFSC) Standard 1.5.1, the interaction of the Advisory Committee for Novel Foods (ACNF), the role of FSANZ pre-market assessment and the complex boundaries relying on definitions to resolve operational significant meanings of 'food', 'novel food' and 'nutritive substances'.
We will visit the important Nutricia® litigation, where the Supreme Court of NSW exposed weaknesses in the architecture of the ANZFSC and then trace how judicial concerns flowed into subsequent food regulatory reform work. The proposed reform of nutritive substances and novel foods is examined, highlighting how novel food reform remains incomplete and what that means for industry managing non-compliance risks.
Dr Janine Curll, Regulatory Manager at Ashbury (Australia), provides this session for regulatory, technical, legal and QA teams to help them understand not only what the legal rules are in this space, but why the system remains difficult to apply. She offers guidance on how industry can navigate the uncertainties.
Attendees will leave with the understanding on:
When a food or ingredient may trigger novel food assessment
Why the distinction between food, novel food and nutritive substance matters
How the Nutricia® case exposed structural weaknesses in the ANZFSC
Why FSANZ's reform work has not fully resolved problems and continues today
How to approach classifications and make risk-based decisions in practice.
*To have a better chance of your questions being addressed, you're welcome to email us the questions before the webinar.
